---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-129592"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T01:57:51.669857+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Esperion completes $100M convertible note issuance and exchange of 2025 notes

## Summary
- Issued $100M aggregate principal of 5.75% Convertible Senior Subordinated Notes due June 15, 2030.
- Exchanged ~$210.1M of existing 4.00% 2025 Notes for ~$57.5M new notes plus ~$153.4M cash.
- Sold ~$42.5M of new notes for cash; net proceeds for general corporate purposes.
- Initial conversion rate 326.7974 shares per $1,000 principal, conversion price ~$3.06 per share.
- New notes are senior unsecured, redeemable after Dec 20, 2027 under certain conditions.

## SEC filing metadata
- accession: 0001104659-24-129592
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465924129592/0001104659-24-129592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465924129592/tm2430949d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-129592
- JSON: https://secwatch.observer/filing/0001104659-24-129592.json
- Plain text: https://secwatch.observer/filing/0001104659-24-129592.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.